KFDA approved Daewoong's EGF, a new drug for diabetic ulcer.

The KFDA authorized to manufacture the first new diabetic ulcer drug on May 30, of which Daewoong pharmaceutical company developed for the first in its high quality, purity and closer to the human molecular over the world through a bio-engineering technology.

EGF (epidermal growth factor) is found in the human body as a natural healing protein substance for injuries leaving no scars behind a...